BackCosmo Pharmaceuticals N.V. Overview

Cosmo Pharmaceuticals N.V. Receivables

Cosmo Pharmaceuticals N.V.'s receivables is $37M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$36.70M
↑ 69.77% YoYΔ $15.08M vs prior year quarter

Peer trimmed avg / median

Loading

Cosmo Pharmaceuticals N.V. Receivables History

Loading

Cosmo Pharmaceuticals N.V. vs. peers: Receivables Comparison

Loading

Cosmo Pharmaceuticals N.V. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Cosmo Pharmaceuticals N.V. (COPN.SW) FAQ

As of the most recent data (June 2026), COPN.SW shows a receivables of $37M. That compares with $22M in the prior-year period — up 69.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, COPN.SW's receivables is now $37M (was $22M) — a 69.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Cosmo Pharmaceuticals N.V. is outperforming or lagging.

Tracking COPN.SW's receivables over time shows whether Cosmo Pharmaceuticals N.V. is scaling, shrinking, or reshaping that part of the business. The current reading is $37M That compares with $22M in the prior-year period — up 69.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Cosmo Pharmaceuticals N.V.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $37M) with ownership activity and broader fundamentals.

Questions & Answers